Exact Mass: 301.15569539999996

Exact Mass Matches: 301.15569539999996

Found 60 metabolites which its exact mass value is equals to given mass value 301.15569539999996, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(Ac)2-L-Lys-D-Ala

(Ac)2-L-Lys-D-Ala; (Ac)2-L-lysyl-D-alanine

C13H23N3O5 (301.1637628)


   

Hept-4-enedioylcarnitine

3-[(6-carboxyhex-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H23NO6 (301.1525298)


Hept-4-enedioylcarnitine is an acylcarnitine. More specifically, it is an hept-4-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Hept-4-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Hept-4-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-Hept-2-enedioylcarnitine

3-[(6-Carboxyhex-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C14H23NO6 (301.1525298)


(2E)-hept-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-hept-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-hept-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-hept-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2Z)-2-(Propan-2-yl)but-2-enedioylcarnitine

3-{[3-carboxy-3-(propan-2-yl)prop-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

C14H23NO6 (301.1525298)


(2Z)-2-(propan-2-yl)but-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2Z)-2-(propan-2-yl)but-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2Z)-2-(propan-2-yl)but-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2Z)-2-(propan-2-yl)but-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-[(4-Aminophenyl)(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]-2-methylaniline

4-[(4-Aminophenyl)(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]-2-methylaniline

C20H19N3 (301.15788940000004)


D004396 - Coloring Agents > D012394 - Rosaniline Dyes

   
   
   

3,4-Didehydro-19-methylnormalindine

3,4-Didehydro-19-methylnormalindine

C20H19N3 (301.15788940000004)


   
   
   
   
   
   
   

(2E)-N-(3,5-DIMETHYLPHENYL)-2-(HYDROXYIMINO)ACETAMIDE

(2E)-N-(3,5-DIMETHYLPHENYL)-2-(HYDROXYIMINO)ACETAMIDE

C21H19NO (301.14665640000004)


   

8-N-BOC-AMINO-1,4-DIOXA-SPIRO[4.5]DECANE-8-CARBOXYLICACID

8-N-BOC-AMINO-1,4-DIOXA-SPIRO[4.5]DECANE-8-CARBOXYLICACID

C14H23NO6 (301.1525298)


   

4-(di-m-Tolylamino)-benzaldehyde

4-(di-m-Tolylamino)-benzaldehyde

C21H19NO (301.14665640000004)


   

(1S,2S)-2-(Bis{[(2-methyl-2-propanyl)oxy]carbonyl}amino)cycloprop anecarboxylic acid

(1S,2S)-2-(Bis{[(2-methyl-2-propanyl)oxy]carbonyl}amino)cycloprop anecarboxylic acid

C14H23NO6 (301.1525298)


   

N-BENZYL-2-(BIPHENYL-3-YL)ACETAMIDE

N-BENZYL-2-(BIPHENYL-3-YL)ACETAMIDE

C21H19NO (301.14665640000004)


   

ethyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,methyl 2-methylprop-2-enoate

ethyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,methyl 2-methylprop-2-enoate

C14H23NO6 (301.1525298)


   
   

(1S,3aR,6aS)-Octahydrocyclopenta[c]pyrrole-1-carboxylic acid tert-butyl ester oxalate

(1S,3aR,6aS)-Octahydrocyclopenta[c]pyrrole-1-carboxylic acid tert-butyl ester oxalate

C14H23NO6 (301.1525298)


   

3-(1,3-DIMETHYL-(4S,5S)-DIPHENYLIMIDAZOLIDIN-2-YL)PYRIDINE

3-(1,3-DIMETHYL-(4S,5S)-DIPHENYLIMIDAZOLIDIN-2-YL)PYRIDINE

C20H19N3 (301.15788940000004)


   
   
   

5-Methoxycarbonylindole-2-boronic acid pinacol ester

5-Methoxycarbonylindole-2-boronic acid pinacol ester

C16H20BNO4 (301.14853100000005)


   

6-Methoxycarbonylindole-2-boronic acid pinacol ester

6-Methoxycarbonylindole-2-boronic acid pinacol ester

C16H20BNO4 (301.14853100000005)


   

Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-7-carboxylate

Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-7-carboxylate

C16H20BNO4 (301.14853100000005)


   

Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-4-carboxylate

Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-4-carboxylate

C16H20BNO4 (301.14853100000005)


   

N-(Furan-2-ylmethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

N-(Furan-2-ylmethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine

C15H20BN3O3 (301.159764)


   

2-N,4-N-bis(3-methoxypropyl)-6-methylsulfanyl-1,3,5-triazine-2,4-diamine

2-N,4-N-bis(3-methoxypropyl)-6-methylsulfanyl-1,3,5-triazine-2,4-diamine

C12H23N5O2S (301.1572378)


   

5-[1-(Acetylamino)-3-methylbutyl]-2,5-anhydro-3,4-dideoxy-4-(methoxycarbonyl)pentonic acid

5-[1-(Acetylamino)-3-methylbutyl]-2,5-anhydro-3,4-dideoxy-4-(methoxycarbonyl)pentonic acid

C14H23NO6 (301.1525298)


   

7-[2-Methoxy-1-(methoxymethyl)ethyl]-7H-pyrrolo[3,2-F] quinazoline-1,3-diamine

7-[2-Methoxy-1-(methoxymethyl)ethyl]-7H-pyrrolo[3,2-F] quinazoline-1,3-diamine

C15H19N5O2 (301.15386739999997)


   

(2R,4S,5R,6R)-5-acetamido-4-amino-6-(diethylcarbamoyl)oxane-2-carboxylic acid

(2R,4S,5R,6R)-5-acetamido-4-amino-6-(diethylcarbamoyl)oxane-2-carboxylic acid

C13H23N3O5 (301.1637628)


   

2-(2,6-Diacetamidohexanoylamino)propanoic acid

2-(2,6-Diacetamidohexanoylamino)propanoic acid

C13H23N3O5 (301.1637628)


   

Hept-4-enedioylcarnitine

Hept-4-enedioylcarnitine

C14H23NO6 (301.1525298)


   

(2E)-Hept-2-enedioylcarnitine

(2E)-Hept-2-enedioylcarnitine

C14H23NO6 (301.1525298)


   

(2Z)-2-(Propan-2-yl)but-2-enedioylcarnitine

(2Z)-2-(Propan-2-yl)but-2-enedioylcarnitine

C14H23NO6 (301.1525298)


   

[(E)-1-[5-(2-methylpropoxymethyl)-2-oxooxolan-3-yl]propan-2-ylideneamino]thiourea

[(E)-1-[5-(2-methylpropoxymethyl)-2-oxooxolan-3-yl]propan-2-ylideneamino]thiourea

C13H23N3O3S (301.1460048)


   
   
   
   
   
   
   

(2E)-9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]non-2-enoate

(2E)-9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]non-2-enoate

C15H25O6- (301.16510500000004)


   

11-beta-Hydroxy-beta-saxitoxinol

11-beta-Hydroxy-beta-saxitoxinol

C10H19N7O4+2 (301.1498454)


   

(E,8R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxynon-2-enoate

(E,8R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxynon-2-enoate

C15H25O6- (301.16510500000004)


   

N-Acetylvalylalanylglycine methyl ester

N-Acetylvalylalanylglycine methyl ester

C13H23N3O5 (301.1637628)


   

N-Acetylvalylglycylalanine methyl ester

N-Acetylvalylglycylalanine methyl ester

C13H23N3O5 (301.1637628)


   

N-Acetyl-glycyl-valyl-alanine methylester

N-Acetyl-glycyl-valyl-alanine methylester

C13H23N3O5 (301.1637628)


   

N-Acetyl-alanyl-valyl-glycine methylester

N-Acetyl-alanyl-valyl-glycine methylester

C13H23N3O5 (301.1637628)


   

4-[(4-Aminophenyl)(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]-2-methylaniline

4-[(4-Aminophenyl)(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]-2-methylaniline

C20H19N3 (301.15788940000004)


D004396 - Coloring Agents > D012394 - Rosaniline Dyes

   

saxitoxin(2+)

saxitoxin(2+)

C10H19N7O4 (301.1498454)


An iminium ion resulting from the protonation of the two imine groups of saxitoxin; major species at pH 7.3.

   

ascr#3(1-)

ascr#3(1-)

C15H25O6 (301.16510500000004)


Conjugate base of ascr#3

   

oscr#3(1-)

oscr#3(1-)

C15H25O6 (301.16510500000004)


A hydroxy fatty acid ascaroside anion resulting from the deprotonation of the carboxy group of oscr#3. The conjugate base of oscr#3 and the major species at pH 7.3.

   
   

14,14-dimethyl-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaene

14,14-dimethyl-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaene

C20H19N3 (301.15788940000004)


   

1-{[(2-ethyl-2,3-dihydroxybutanoyl)oxy]methyl}-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

1-{[(2-ethyl-2,3-dihydroxybutanoyl)oxy]methyl}-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

C14H23NO6 (301.1525298)